Alliancebernstein L.P. decreased its holdings in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 13.2% in the first quarter, Holdings Channel reports. The firm owned 38,664 shares of the company’s stock after selling 5,900 shares during the quarter. Alliancebernstein L.P.’s holdings in Schrödinger were worth $2,950,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Signaturefd LLC bought a new position in shares of Schrödinger in the fourth quarter valued at approximately $36,000. Arkadios Wealth Advisors raised its stake in shares of Schrödinger by 82.3% in the first quarter. Arkadios Wealth Advisors now owns 483 shares of the company’s stock valued at $36,000 after acquiring an additional 218 shares during the last quarter. TCI Wealth Advisors Inc. bought a new position in shares of Schrödinger in the first quarter valued at approximately $39,000. Valeo Financial Advisors LLC raised its stake in shares of Schrödinger by 22.4% in the fourth quarter. Valeo Financial Advisors LLC now owns 601 shares of the company’s stock valued at $48,000 after acquiring an additional 110 shares during the last quarter. Finally, Advisory Services Network LLC bought a new position in shares of Schrödinger in the fourth quarter valued at approximately $59,000. Institutional investors own 50.09% of the company’s stock.
SDGR opened at $76.41 on Friday. The stock’s fifty day simple moving average is $71.34. Schrödinger, Inc. has a 52 week low of $46.27 and a 52 week high of $117.00. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of -424.48 and a beta of 0.96.
A number of research analysts have recently issued reports on the stock. Craig Hallum assumed coverage on shares of Schrödinger in a research note on Tuesday, May 25th. They issued a “buy” rating and a $85.00 target price for the company. Zacks Investment Research upgraded shares of Schrödinger from a “sell” rating to a “hold” rating in a research note on Thursday, May 13th. BMO Capital Markets lowered their price target on shares of Schrödinger from $110.00 to $104.00 and set an “outperform” rating for the company in a report on Wednesday, March 24th. Finally, Morgan Stanley lowered their price target on shares of Schrödinger from $89.00 to $83.00 and set an “equal weight” rating for the company in a report on Wednesday, May 12th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Schrödinger has a consensus rating of “Buy” and an average target price of $85.67.
Schrödinger Company Profile
SchrÃ¶dinger, Inc provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.
See Also: How does quantitative easing work?
Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGR).
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.